½ðÑÇÌåÓý¹Ù·½appÏÂÔØ

2003-ÖÁ½ñ  ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ··½¼Áѧ½ÌÑÐÊÒ£¬½ÌÊÚ£»½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·µÚÒ»¸½ÊôÒ½Ôº£¬ºôÎüÄڿƼ°ÖÐÒ½ÄÚ¿ÆÃÅÕï
2011-2013 ÃÀ¹úÂíÀïÀ¼´óѧҽѧԺ£¬·ÃÎÊѧÕß
2000-2003 ÖÐɽ´óѧÉúÃü¿ÆѧѧԺ£¬²©Ê¿ºó£¬·Ö×Ó»¯Ñ§ÉúÎﻯѧÓëÖÐÒ½Ò©£¬ µ¼Ê¦Ðì°²Áú½ÌÊÚ
1997-2000  ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·£¬²©Ê¿Ñо¿Éú£¬µ¼Ê¦ÀµÊÀ¡½ÌÊÚ
1994-1997  ¸£½¨ÖÐҽѧԺ£¬Ë¶Ê¿Ñо¿Éú
1989-1994  ¸£½¨ÖÐҽѧԺ  ´óѧ±¾¿Æ

ÖÐÒ©¼°¸´·½Ò©ÀíҩЧÑо¿£¬·½¼ÁµÄÅäÎé¹æÂɼ°ÁÙ´²Ó¦ÓÃÑо¿

Ö÷³Ö
1.µÚËÄÅúÈ«¹úÖÐÒ½ÓÅÐãÈ˲ÅÑÐÐÞÏîÄ¿£¬¹úÖÐÒ½Ò©È˽̷¢¡¾2017¡¿24ºÅ£¬¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö£¬2017.12-2020.12.
2.ÁéÖ¥µ°°×1z-8ÖÎÁÆÌÇÄò²¡µÄҩЧ¼°»úÖÆÑо¿ ÖÐҩѧԺÖÐҩѧ¿Æ½¨Éè¿ÆÑÐÏîÄ¿£¬2016Äê.
3.´ÓѪÇåÒ©»¯¼°´úл×éѧÑо¿ÉöÆøÍèÒõÖÐÇóÑôÅäÎé»úÀí ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ· ¡°Ð½»ð¡±¼Æ»® 2015 £¨±àºÅ£ºXH20140112£©10Íò.
4.²ð·½ÉöÆøÍè¶ÔÉöÑôÐéÄ£ÐÍ´óÊóHPAÖáÓ°ÏìµÄʵÑéÑо¿    ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÓÏîÄ¿£¬ 2007.
5.¼ÁÐÔζÅäÎéҩЧ»ù´¡³õ̽    ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøַУ¼¶¿ÎÌ⣬2006.
6.¡°»ùÓÚÖÐÒ©Ò©ÐԵġ°ÐÔ£­Ð§£­³É·Ö¡±Êý¾Ý¿âµÄ½¨Á¢¼°Êý¾ÝÍÚ¾ò¼¼ÊõµÄÓ¦Óà    ¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö¿ÎÌ⣬ 2007 7.¡°ÖÐÒ½²»Í¬ÌåÖÊÀàÐÍÓëHLA¶þÀà»ùÒò¶à̬ÐÔÏà¹ØÐÔµÄÑо¿¡±    ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖúÏîÄ¿£¬ 2002.
²ÎÓ룺
1.ÒÔ·½¼Á±¦Ñ§Ï°Æ½Ì¨ÎªÒÀÍеķ½¼ÁѧÔÚÏß¿ª·Å¿Î³ÌµÄ½¨ÉèÓëÓ¦ÓÃÑо¿  2018¸ßµÈ½ÌÓý½ðÑÇÌåÓý¹Ù·½appÏÂÔظĸïÏîÄ¿Ê¡¼¶Á¢Ï2Íò.
2.  ³¦µÀ´úлÓëÃâÒßÑ×Ö¢Ñо¿ÍÅ¶Ó  ¹ã¶«ÆÕͨ¸ßУ´´ÐÂÍŶÓÏîÄ¿£¨ÖÐҩѧԺÖÐҩѧÖصãѧ¿Æ¿ÆÑд´ÐÂÍŶӽ¨ÉèÏîÄ¿£©2016.9  3Íò.
3. »ùÓÚTyk2/STAT3ÐźÅͨ·½éµ¼µÄ×ØÉ«Ö¬·¾Ï¸°û·Ö»¯¼°ÄÜÁ¿´úл̽ÌÖ¸ùƤÜÕÒÖÖÆ·ÊÅֵĻúÖÆÑо¿   ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðίÏîÄ¿£¨±àºÅ£º81303281£©23Íò 2014.01-2016.12.
4.  ST-FÖÎÁÆ2ÐÍÌÇÄò²¡ÐÂÒ©µÄÁÙ´²Ç°Ñо¿  ¹ã¶«Ê¡½ÌÓý²¿²úѧÑнáºÏÏîÄ¿  £¨ÏîÄ¿±àºÅ£º2012B091100184£©2012.
5. ¡¶·½¼Áѧ¡·Ê¡¼¶¾«Æ·¿Î³Ì     ¹ã¶«Ê¡½Ìί£¬2010.
6£® ÉöÆøÍèÒõÖÐÇóÑôÅäÎé»úÀí¼°ÎïÖÊ»ù´¡Ñо¿     ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬ 2006.
7£® ÂéÐÓ¸ÊʯÌÀ¶Ô¿¹Ô­ÓÕµ¼Ð¡ÊóÖ§Æø¹ÜÏø´­µÄ×÷ÓûúÀí      ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·´´Ð»ù½ð£¬ 2004.
8.  ¿ª·¢¾ßÓиÄÉÆ˯ÃßÖÊÁ¿±£½¡¹¦ÄܵÄÖÐÒ©ÌáÈ¡Îï     ±±¾©°®·ÒʳƷÓÐÏÞ¹«Ë¾£¨ºáÏò¿ÎÌ⣩£¬2004.
9. ¡¶·½¼Áѧ¡·»ùÓÚÍøÉÏ×ÊÔ´ÀûÓõĽðÑÇÌåÓý¹Ù·½appÏÂÔظĸïÊÔÑéÑо¿     ¹ã¶«Ê¡151¹¤³Ì¿ÎÌ⣬ 2004.
10.  ·½¼ÁѧCAI½ðÑÇÌåÓý¹Ù·½appÏÂÔؿμþ½¨ÉèµÄÑо¿     ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·ÖÐҩѧԺ£¬ 2004.
11£® ¡°ÖйúÈËHLAÃâÒß¹¦ÄÜÏà¹Ø»ùÒòµ÷¿ØÇøSNPs¼°ÆäÓë¼²²¡µÄ¹Øϵ¡± ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖúÏîÄ¿£¨2002£­2004£©.
12£® ¡°ÖйúÈËHLA¶þÀ࿹ԭµÄ»ùÒò×éSNPÑо¿¡± ¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÖصãÏîÄ¿£¨2003£­2005£©

·½¼Áѧ£¬ÖгÉҩѧ£¬ÏÖ´úҽѧµ¼ÂÛ£¬ÖÐҽѧµ¼ÂÛ£¬ÆøÒ»ÔªÂÛÓëÖÐÒ½ÁÙ´²

• [1] Ying-yu Lu, Jian Liang, Shu-Xian Chen, Bing-xin Wang, Han Yuan, Can-tao Lib,Ya-yun Wu, Yan-fang Wu, Xu-guang Shi, Jie Gao£¨Í¨Ñ¶×÷Õߣ©, Shao-zhen Hou. Phloridzin alleviate colitis in mice by protecting the intestinal brush border and improving the expression of sodium glycogen transporter 1. Journal of Functional Foods 45 (2018) 348¨C354.
  [2] ÀîÅô£¬¸ß½à(ͨѶ×÷Õß)£¬ºîÉÙÕê. ÉöÆøÍè¡°ÒõÖÐÇóÑô¡±ÅäÎé¶ÔÌåÄÚÎÚÍ·¼î¡¢´ÎÎÚÍ·¼îº¬Á¿µÄÓ°Ïì. ÄÚÃɹÅÖÐÒ½Ò©£¬2017.£¨11£©£º91-92.
  [3] Jie Gao, Junling Li, Bao-Jun Li, Ezra Yagil, Jianshe Zhang, Shao Jun Du¡£Expression and Functional Characterization of Smyd1a in Myofibril Organization of Skeletal Muscles. Plos One, January  ( 9) , e86808 ,2014 £¨13Ò³£©.
  [4] Li H, Zhong Y, Wang Z, Gao J, Xu J, Chu W, Zhang J, Fang S, Du SJSmyd1b is required for skeletal and cardiac muscle function in zebrafish. Mol Biol Cell. 2013 Nov;24(22):3511-21.
  [5] Xu J, Jie Gao,  Li J, Xue L, Clark KJ, Ekker SC, Du SJ.  (2012). ¡°Functional analysis of slow Myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow muscles¡±.   J Genet Genomics., 2012, Feb;39(2): 69-80.
  [6] ºîÉÙÕ꣬¸ß½à. Õë¶ÔÖÐҩѧÀàרҵÌصãµÄ·½¼Áѧ½ðÑÇÌåÓý¹Ù·½appÏÂÔØÌå»á[J]. ÖÐÒ½ÔÓÖ¾£¬2012£¬53£¨£¹£©£º807-809.
  [7] ¸ß½à, ËκñÅÎ, Ñîêîΰ. ²ð·½ÉöÆøÍè¶ÔÉöÑôÐé´óÊóÉöÉÏÏÙƤÖʳ¬Î¢½á¹¹µÄÓ°Ïì[J]. ʱÕä¹úÒ½¹úÒ©2011, (8): 1810-1812.
  [8] ÀèͬÃ÷,¸ß½à,Íõ¹ðÏã.ÎÚ÷ˮ¼åÒºÕò¾²´ßÃß¼°¿¹¾ªØÊ×÷ÓÃʵÑéÑо¿[J]. ÖÐҽѧ±¨,2011,26(7):818-820.
  [9] ÀèͬÃ÷,¸ß½à,±´Ø¹. ¹È×¼°Â¹±Þ¶ÔÉöÑôÐé´óÊó²»ÓýÖ¢µÄʵÑéÑо¿[J]. ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøַѧ±¨,2011,28(4):406-408.
  [10] ÀèͬÃ÷,Íõ¹ðÏã,¸ß½à,±´Ø¹. ¸½×ӸɽªÅäÎéÎÂÑôͨÂö×÷ÓõÄʵÑéÑо¿[J]. ÖÐÒ©ÐÂÒ©ÓëÁÙ´²Ò©Àí,2011,22(4):373-375.
  [11] ÍôÓñ÷,ÁÖÏþ±ù,ÀîÕþľ,¸ß½à,³Âΰè¯,׿Á®¼Ñ,³Â¹¦³É. ´ÓÉöÆøÍèÅäÎé¹æÂÉÖÐ̸¡°ÒõÖÐÇóÑô¡±µÄʵÖÊ[J]. ÐÂÖÐÒ½,2011,43(3):147-148.
  [12] ÂÀÓ¢,¸ß½à. ¹ðÖ¦¸Ê²ÝÌÀ¡°ÐÁ¸Ê»¯Ñô¡±ÅäÎéµÄʵÑéÑо¿[J].ÖÐÒ©²Ä2010,33£¨8£©£º1296-1299.
  [13] ¸ß½à£¬³ÂÑ࣬Áּᣬ±´êÅ.dzÎö½â±íÒ©ÐÔζÓëÖ÷Òª»¯Ñ§³É·Ö¡¢ÏÖ´úÒ©Àí×÷ÓõÄÏà¹ØÐÔ[J]. ÖÐÒ©²Ä2010,33£¨2£©£º317-319.
  [14] ¸ß½à. ¹ðÖ¦¸Ê²ÝÌÀ¡°ÐÁ¸Ê»¯Ñô¡±ÅäÎéµÄ»¯Ñ§Ñо¿[J]. н®ÖÐÒ½Ò©25 (supplemental): 38-40.
  [15] ¸ß½à£¬ÀîÕþľ£¬ÀèͬÃ÷£¬³ÂÃô£¬Ñîêî࣬ÎâÓ£¬ÍõÅæ¼á. ´Ó²ð·½ÉöÆøÍè¶ÔÉöÑôÐéÄ£ÐÍ´óÊóHPAÖáµÄÓ°Ïì³õ̽¡°ÒõÖÐÇóÑô¡±ÅäÎé»úÀí[J]. ËÄ´¨ÖÐÒ½£¬2007£¬25£¨7£©£º15-17.
  [16] ¸ß½à£¬ÂÀ·ï¾ê£¬ÁÖ½¯º£¡£ÖÐҽ̵ʪÌåÖÊÓëHLA-IIÀà»ùÒòÏà¹ØÐÔÑо¿[J]. ÉÂÎ÷ÖÐÒ½£¬2007£¬28£¨5£©£º622-625.
  [17] ¸ß½à£¬ÂÀ·ï¾ê£¬ÁÖ½¯º£¡£ÖйúÈ˳£¼ûHLA-DPB1²»Ã÷È·ÔÓºÏ×ÓSSP·ÖÐͽâ¾ö·½°¸[J]. ÏÖ´úÉúÎïѧ½øÕ¹£¬2007£¬7£¨2£©£º175-178.
  [18] ¸ß½à£¬ÀîÃ÷£¬ÁõÄÝ£¬ÖªÄ¸Äþ¿¹ÒҸβ¡¶¾×÷ÓõÄÌåÄÚÍâʵÑé[J]. ɽÎ÷ÖÐҽѧԺѧ±¨£¬2007£¬8£¨2£©£º16-18.
  [19] ³ÂÃô£¬ÀîÕþľ£¬¸ß½à. ¡°ÒõÖÐÇóÑô¡±ÀíÂÛ¼°ÆäÖ÷·½ÉöÆøÍèµÄÑо¿Ì½ÌÖ[J]. ºÓÄÏÖÐҽѧԺѧ±¨£¬2007£¬22£¨3£©£º12-14.
  [20] SHANGWU CHEN, Ph.D., FENGJUAN LV, M.S., JIE GAO, Ph.D.,  JIANGHAI LIN, M.S.,ZEHUAN LIU, Ph.D., YONGGUI FU, M.S., YIN LIU, M.S., BIN LIN, M.S., YI XIE, M.S.,XIANGPENG REN, M.S., YUNPING XU, M.S., XINLAN FAN, M.S., and ANLONG XU, Ph.D. HLA Class II Polymorphisms Associated with the PhysiologicCharacteristics Defined by Traditional Chinese Medicine:Linking Modern Genetics with an Ancient Medicine J ALTERN COMPLEM MED£¬2007£¬13£¨2£©231-239.
  [21] ¸ß½à£¬ÁõÄÝ£¬ÖìÓîͬ£¬ÀîÃ÷. Chinonin¿¹HSV-II¼°¶ÔHSV-II DNAÓ°ÏìµÄʵÑéÑо¿[J]. ÖÐÒ©²Ä£¬2006£¬29£¨12£©£º1332-1334.
  [22] ¸ß½à£¬ÂÀ·ï¾ê£¬ÁÖ½¯º£. ÖÐÒ½ðöѪÌåÖÊÓëHLA-IIÀà»ùÒòÏà¹ØÐÔÑо¿[J]. ÖлªÁÙ´²Ò½Ñ§Ñо¿ÔÓÖ¾£¬2006£¬12£¨22£©£º2977-2979.
  [23] ÀèͬÃ÷£¬Íõ¹ðÏ㣬ȫÊÀ½¨£¬¸ß½à. ÂéÐÓ¸ÊʯÌÀ¶ÔÏø´­Ä£ÐÍСÊóÑõ×ÔÓÉ»ù´úлµÄÓ°Ïì[J]. ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøַѧ±¨£¬2006£¬23£¨6£©£º500-502.
  [24] ÀèͬÃ÷£¬¸µÒæȺ£¬¸ß½à£¬ÎººÏΰ. ¶¨´­ÌÀ¶ÔÏø´­»¼ÕßÆøµÀÑ×Ö¢µÄÓ°Ïì[J]. ÖлªÁÙ´²Ò½Ñ§Ñо¿ÔÓÖ¾£¬2005£¬11£¨5£©£º606-608.
  [25] ÖÓÕñ¹ú£¬Áõï²Å£¬ ÀµÊÀ¡£¬¸ß½à£¬ ³ÌÊçÒâ. ²¹ÉöÒæÖÇ·½¶ÔÀÏÄêÐÔ³Õ´ôÄ£ÐÍ´óÊóÉñ¾­µÝÖÊÊͷŵÄÓ°Ïì[J]. ÖйúÁÙ´²¿µ¸´,2005£¬9£¨44£©:167-170.
  [26] F. Lv£¬J. Gao£¬ J. Lin£¬Z. Liu£¬Y. Xu£¬X. Ren£¬H. Zhang£¬A. Xu  Characterization of a novel HLA -DQB1 allele, DQB1*020102.  Tissue Antigens,2004£º64£º619-620.
  [27] F. Lv£¬J. Gao£¬ J. Lin£¬Z. Liu£¬Y. Fu£¬B. Lin£¬Y. Liu£¬A. Xu,  A novel HLA-DRB1 allele, DRB1*0449, with a rare point mutation found in the Han population of Guangdong China. Tissue Antigens,2004£º63£º612-613.
  [28] F. Lv£¬ J. Lin£¬Z. Liu£¬J. Gao£¬Y. Fu£¬A. Xu,  Identification of a novel HLA-DPB1 allele -DPB1*0102.  Tissue Antigens,2004£º64£º512-514.
  [29] ¸ß½à£¬ÀµÊÀ¡£¬ÈÄÑà. ²¹ÉöÒæÖÇ·½¶ÔAlzheimer²¡Ä£ÐÍ´óÊóÄÔÄÚ¦Â-µí·ÛÑùÇ°Ìåµ°°×µÄÓ°Ïì[J].  ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾£¬2002£¬22£¨9£©£º677-679.
  [30] ¸ß½à£¬ÀµÊÀ¡£¬ºú¾µÇ壬µÈ. ²¹ÉöÒæÖÇ·½¶ÔAlzheimer²¡Ä£ÐÍ´óÊóÍ»´¥µÄÓ°Ïì[J]. ÖйúÖÐÒ½»ù´¡Ò½Ñ§ÔÓÖ¾£¬2002£¬8£¨2£©£º25.
  [31] ÈÄÑ࣬¸ß½à£¬ÀµÊÀ¡. D°ëÈéÌǺϲ¢Meynert»ùµ×ºËËð»Ù¶Ôº£Âí³¤Ê±³ÌÔöÇ¿ºÍÍ»´¥ÐÎ̬µÄÓ°Ïì[J].
  [32] ÖÓÕñ¹ú£¬Áõï²Å£¬ÀµÊÀ¡£¬¸ß½à£¬³ÌÊçÒâ. ²¹ÉöÒæÖÇ·½¶ÔÓÉA¦ÂƬ¶ÎÉñ¾­¶¾ÐÔÓÕµ¼NG108-15ϸ°ûÀÏÄêÐÔ³Õ´ôÄ£ÐÍÉñ¾­µÝÖÊÊÍ·ÅÓ°ÏìµÄÑо¿[J]. ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾£¬2002£¬22£¨1£©£º50-53.
  [33] ¸ß½à£¬ÀµÊÀ¡. ²¹ÉöÒæÖÇ·½¶ÔAlzheimer²¡Ä£ÐÍ´óÊóÄÔÄÚ¦Â-µí·ÛÑùÇ°Ìåµ°°×±í´ïµÄÓ°Ïì[J]. ½âÆÊѧÑо¿£¬2002£¬24£¨1£©£º69.
  [34] ¸ß½à. ÖÐÒ©ÖÎÁÆAlzheimer²¡¿ÉÄÜ×÷Óû·½ÚµÄ̽ÌÖ[J]. ÖйúÖÐÒ½Ò©ÐÅÏ¢ÔÓÖ¾, 2000,7(2):5-7.
  [35] ¸ß½à, ÀµÊÀ¡. ¦Â-µí·ÛÑùµ°°×¼°ÆäÇ°Ìåµ°°×ÓëAlzheimer²¡µÄ¹Øϵ[J]. ÏÖ´úÕï¶ÏÓëÖÎÁÆ, 1999,10(4):213-216.
  [36] ¸ß½à, ÀîÖ²ÑÓ. Ö§Æø¹ÜÏø´­ÖÐҽ΢¹Û±æÖ¤µÄÑо¿½øÕ¹[J]. ¸£½¨ÖÐҽѧԺѧ±¨, 2000,10 (S):86.
  [37] ÀîÖ²ÑÓ, ¸ß½à£¬ÁõÇ廪. Ïø´­·¢×÷ÆÚÀäÈÈÏøÖ¤ÃâÒß¹¦ÄܺÍÊÉËáÁ£Ï¸°û±ä»¯µÄÁÙ´²Ñо¿. ¸£½¨ÖÐÒ½Ò©, 2000,31(5):3£­4

• Ö÷ÒªÂÛÖø¡¢½Ì²Ä£º 1. ·½¼ÁµÄÏÖ´úÑо¿£¬    ÖÐÒ½¹Å¼®³ö°æÉ磬2006.12£¬Ö÷±à
  2. ·½¼Áѧ£¨ÐÂÊÀ¼ÍÈ«¹ú¸ßµÈÖÐҽҩԺУ½Ì²Ä£©£¬    ¿Æѧ³ö°æÉ磬2004.6£¬±àί
  3. ÖгÉҩѧ£¬    ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·£¬2007.3£¬Ö÷±à
  4. ÏÖ´úҽѧµ¼ÂÛ£¬    ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·£¬2006£¬±àί
  5. ÖгÉÒ©µÄÁÙ´²Ó¦Ó㬠   ½ðÑÇÌåÓý¹Ù·½µÇ¼Èë¿ÚÍøÖ·£¬2006.7£¬±àί